Brookdale Senior Living Inc. BKD R2KR3KPHARMA

Q: What is the current share price of Brookdale Senior Living Inc. (BKD)?

As of 2026-10-23 16:27 PDT, Brookdale Senior Living Inc. (BKD) trades at $10.08 on NYSE. Its 52-week range is $7.19 to $16.77.

Q: What is the market capitalisation of BKD?

Brookdale Senior Living Inc. (BKD) has a market capitalisation of $2.41B on NYSE.

Q: What is the P/E ratio of BKD?

BKD trades at a trailing price-to-earnings (P/E) ratio of -17.38. The industry average P/E is 25.45. Its price-to-book (P/B) ratio is -83.64.

Q: Is BKD a good stock to buy?

This page provides a data-driven analysis of Brookdale Senior Living Inc. (BKD), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Healthcare · Medical Care Facilities · United States

https://www.brookdale.com

Company Profile ↓

$10.08

+36.40% 1Y

Mkt Cap$2.41B

P/E-17.38

P/B-83.64

52W High$16.77

52W Low$7.19

Book Value$-0.12

EPS (TTM)$-0.58

Company Overview

Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding, multi-story communities and freestanding single-story communities, which offer housing and 24-hour assistance with activities of daily living for the Company's residents. This segment operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that provides various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and healthcare needs. It manages communities on behalf of others. The company was incorporated in 2005 and is headquartered in Brentwood, Tennessee.

Why Investors Should Care

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

Dec 2025 Revenue of $3.19B (+2.2% YoY); net profit $-262.69M.
Trailing 12 Months Year-on-year growth — revenue -8.9%.
5-Year Trend Long-term compounding — revenue CAGR 3.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	3.01%
1 Year:	-8.90%

Stock Price Performance

1 Year:	+36.40%
6 Months:	-27.38%
3 Months:	-34.84%
1 Month:	-8.94%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish

52-Week Range 30% of range

$7.19 $16.77

Trend Signals

Price vs 50-DMABelow
Price vs 200-DMABelow
RSI (14)33.83 · Neutral

Price Performance

1M-8.94%

3M-34.84%

6M-27.38%

1Y+36.40%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Generates positive free cash flow.

CONS

Trading 39.9% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

-17.38

Industry PE

25.45

Forward P/E

84.00

PEG Ratio

0.28

Book Value

$-0.12

Price to Book

-83.64

P/S

0.82

EV/EBITDA

16.51

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

3.01%

Profit 5Y

Revenue (YoY)

-8.90%

Earnings (YoY)

Profitability & Returns

ROCE

0.25%

ROE

ROA

1.54%

Profit Margin

-4.72%

Op Margin

6.81%

Gross Margin

28.26%

EPS (Latest Qtr)

$0.10

EPS (TTM)

$-0.58

Balance Sheet & Liquidity

Debt/Equity

Quick Ratio

0.85

Current Ratio

1.14

Debt

$5.49B

Total Assets

$5.90B

Current Assets

Working Capital

Ownership

Promoter Holding

1.96%

Chg in Prom Hold

0.00%

FII / Inst Holding

117.99%

Chg in FII Hold

-0.81%

Financial Snapshot

Enterprise Value

$2.41B

Total Revenue (TTM)

$2.93B

EBITDA

$464.88M

Free Cash Flow

$22.96M

Operating Cash Flow

$223.87M

Shares Outstanding

238.82M

Gross Margin

28.26%

Payout Ratio

0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	BKD Brookdale Senior Living Inc. R2KR3KPHARMA	10.08	-17.38	$2.41B	0.00%	0.25%	-	3.01%	-
2	LLY Eli Lilly and Company SPXR3KPHARMA	1,273.46	42.83	$1.14T	0.60%	-	102.29%	7.20%	11.41%
3	JNJ Johnson & Johnson SPXR3KPHARMA	263.81	30.60	$635.76B	1.98%	14.88%	25.74%	2.43%	4.76%
4	ABBV AbbVie Inc. SPXR3KPHARMA	285.64	80.69	$504.76B	2.54%	10.47%	-129.24%	1.75%	-29.06%
5	UNH UnitedHealth Group Incorporated SPXR3KPHARMA	418.09	26.85	$375.28B	2.47%	9.74%	14.15%	10.40%	5.43%
6	MRK Merck & Co., Inc. SPXR3KPHARMA	145.27	116.22	$358.41B	2.31%	-	6.96%	5.64%	10.01%
7	NVS Novartis AG PHARMA	151.12	22.83	$287.24B	3.36%	21.09%	30.35%	9.25%	26.22%
8	AZN AstraZeneca PLC NDXPHARMA	171.49	25.63	$265.96B	2.00%	15.97%	21.96%	9.82%	45.96%
9	TMO Thermo Fisher Scientific Inc. SPXR3KPHARMA	673.82	36.30	$249.14B	0.29%	8.14%	13.51%	8.81%	12.95%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Mar 2015	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	1.19B	1.16B	1.12B	-	1.04B	1.02B	1.01B	-	1.01B	865.91M	807.98M	749.45M	723.29M	641.65M	677.82M	689.52M	757.46M	753.26M	750.79M	757.29M	782.83M	777.54M	784.17M	813.86M	812.94M	813.16M	764.86M	718.58M
Gross Profit	370.44M	363.83M	355.06M	-	362.03M	379.65M	354.14M	-	358.28M	314.11M	290.38M	-	292.62M	285.96M	251.63M	-	239.13M	227.07M	199.08M	-	302.94M	158.36M	146.68M	127.34M	129.44M	123.38M	127.92M	138.46M	194.46M	187.50M	185.68M	184.90M	204.31M	204.82M	198.12M	223.09M	215.92M	210.85M	216.36M	205.77M
Operating Income	-116.87M	-43.12M	3.66M	-8.87M	41.35M	58.29M	47.65M	-178.37M	48.13M	30.17M	-350.97M	2.62M	-413.83M	-137.59M	3.63M	-46.45M	16.66M	2.21M	-20.22M	-43.15M	14.90M	-59.98M	-55.12M	-61.59M	-52.49M	-48.85M	-53.53M	-34.05M	19.21M	7.82M	41.16M	-6.34M	19.25M	19.16M	10.26M	29.58M	14.91M	-53.84M	51.78M	85.25M
Net Income	-130.45M	-84.55M	-68.22M	-174.26M	-48.77M	-35.45M	-51.69M	-268.49M	-126.30M	-46.29M	-413.88M	15.06M	-457.19M	-165.49M	-37.12M	131.54M	-42.59M	-55.47M	-78.46M	-91.41M	369.51M	-118.40M	-124.97M	-108.28M	-83.58M	174.28M	-100.01M	-84.42M	-28.36M	-44.55M	-4.51M	-48.80M	-29.57M	-37.73M	-50.72M	-64.98M	-43.02M	-114.73M	-6.89M	23.27M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.23	-0.30	-0.42	-	2.00	-0.65	-0.68	-0.59	-0.45	0.89	-0.54	-0.45	-0.15	-0.20	-0.02	-0.22	-0.13	-0.17	-0.22	-0.28	-0.18	-0.48	-0.03	0.10

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	1.93B	2.10B	2.28B	2.46B	2.77B	2.89B	3.83B	4.96B	4.98B	4.75B	4.53B	4.06B	3.54B	2.76B	2.83B	3.02B	3.13B	3.19B
Gross Profit	-	-	-	-	-	-	-	1.45B	1.44B	1.25B	1.07B	876.54M	797.15M	500.95M	594.41M	746.70M	799.31M	837.55M
Operating Income	-240.14M	29.78M	65.99M	88.75M	80.94M	131.29M	-84.91M	-165.21M	-31.08M	-270.05M	-594.25M	-44.50M	-97.69M	-216.94M	-42.69M	18.41M	46.53M	13.50M
Net Income	-373.24M	-66.25M	-48.90M	-69.05M	-66.47M	-3.58M	-148.99M	-457.48M	-404.40M	-571.42M	-528.26M	-267.93M	82.02M	-99.29M	-238.43M	-189.01M	-201.94M	-262.69M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-2.82	-1.44	0.44	-0.54	-1.25	-0.84	-0.89	-1.12

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	4.65B	4.53B	4.47B	4.71B	4.74B	10.42B	10.05B	9.22B	7.68B	6.47B	7.19B	6.90B	6.41B	5.94B	5.57B	6.34B	5.95B
Total Equity	1.42B	960.60M	1.09B	1.06B	1.04B	996.99M	1.02B	2.88B	2.46B	2.08B	1.53B	1.02B	696.36M	800.43M	697.40M	582.61M	403.66M	212.47M	-44.75M
Cash & Equivalents	100.90M	53.97M	66.37M	81.83M	30.84M	69.24M	58.51M	104.08M	88.03M	216.40M	222.65M	398.27M	240.23M	380.42M	347.03M	398.85M	277.97M	308.93M	279.12M
Long Term Debt	-	-	2.46B	2.50B	2.35B	2.09B	2.14B	3.34B	3.46B	3.41B	3.38B	3.35B	3.22B	3.85B	3.78B	3.78B	3.66B	4.02B	4.22B
Total Liabilities	-	-	3.56B	3.47B	3.43B	3.71B	3.72B	7.54B	7.59B	7.14B	6.15B	5.45B	6.50B	6.10B	5.71B	5.35B	5.17B	6.12B	6.00B
Current Liabilities	-	-	695.97M	606.36M	620.95M	1.13B	870.84M	873.90M	840.15M	731.14M	1.10B	773.33M	1.05B	690.73M	631.95M	641.21M	600.12M	579.76M	567.92M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	136.77M	237.22M	228.24M	268.43M	290.97M	366.12M	242.65M	292.37M	373.65M	378.36M	203.96M	216.41M	205.65M	-94.63M	3.28M	162.92M	166.18M	218.03M
Investing Cash Flow	-166.44M	-351.43M	-136.50M	-203.90M	-455.33M	-264.81M	-314.88M	-568.98M	171.80M	-602.33M	288.77M	-225.54M	-425.11M	181.46M	-67.43M	-113.36M	-278.07M	-455.95M
Financing Cash Flow	-17.26M	126.61M	-76.28M	-115.52M	202.77M	-112.04M	117.80M	260.56M	-422.11M	229.20M	-325.06M	-139.39M	382.91M	-113.66M	100.38M	-174.44M	142.06M	201.09M
Capital Expenditure	-189.03M	-117.45M	-93.68M	-160.13M	-208.41M	-257.53M	-304.25M	-411.05M	-333.65M	-213.89M	-225.47M	-304.09M	-185.87M	-176.66M	-196.92M	-233.21M	-201.25M	-201.53M
Free Cash Flow	-52.26M	119.77M	134.56M	108.30M	82.56M	108.59M	-61.59M	-118.69M	40.00M	164.47M	-21.51M	-87.68M	19.78M	-271.29M	-193.64M	-70.28M	-35.07M	16.50M
Share Buybacks	29.19M	0	0	17.61M	0	0	0	0	9.64M	0	4.26M	23.95M	18.12M	0	0	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	29.2%	28.9%	26.4%	23.6%	21.6%	22.5%	18.2%	21.0%	24.8%	25.6%	26.2%
Operating Margin %	-12.5%	1.4%	2.9%	3.6%	2.9%	4.5%	-2.2%	-3.3%	-0.6%	-5.7%	-13.1%	-1.1%	-2.8%	-7.9%	-1.5%	0.6%	1.5%	0.4%
Net Margin %	-19.4%	-3.2%	-2.1%	-2.8%	-2.4%	-0.1%	-3.9%	-9.2%	-8.1%	-12.0%	-11.7%	-6.6%	2.3%	-3.6%	-8.4%	-6.3%	-6.5%	-8.2%
ROE %	-38.9%	-6.1%	-4.6%	-6.7%	-6.7%	-0.4%	-5.2%	-18.6%	-19.5%	-37.3%	-51.8%	-38.5%	10.2%	-14.2%	-40.9%	-46.8%	-95.0%	587.0%
ROCE %	-	0.8%	1.7%	2.3%	2.3%	3.4%	-0.9%	-1.8%	-0.4%	-4.1%	-10.4%	-0.7%	-1.6%	-3.8%	-0.8%	0.4%	0.8%	0.3%

Shareholding Pattern

Insiders

1.96%

Institutions

117.99%

Public Float

120.35%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	9.90%	23.65M	$239.32M
2	WCM Investment Management, LLC	6.05%	14.45M	$146.26M
3	Deerfield Management Company, L.P	4.87%	11.64M	$117.77M
4	Antipodes Partners Ltd.	4.64%	11.09M	$112.25M
5	Vanguard Portfolio Management LLC	4.53%	10.82M	$109.48M
6	Vanguard Capital Management LLC	4.27%	10.19M	$103.12M
7	Carronade Capital Management, Lp	4.14%	9.88M	$99.97M
8	Wellington Management Group, LLP	4.03%	9.63M	$97.49M
9	Maple Rock Capital Partners, Inc.	3.72%	8.89M	$89.95M
10	Geode Capital Management, LLC	2.91%	6.95M	$70.38M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for BKD

Google News ue, 06 Oct 2026

3 Reasons to Sell BKD and 1 Stock to Buy Instead - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOMTE5aG1aeU01UmhjbHBVS3VpT25lZWd3cEhXMkZONGhKcGFjNk9hS3pWWTc3ZENKZFJiQVlNa0RQaG03eDV2dWhaaVNVZDVad094UWZMN2YtZ0lfWV8zMEpaWG5RV2lxMWNJS3pRclh0My1NMjNKYm9YQU5MMW13UmxFZlE1NjZxcWFvYl…

Google News ue, 06 Oct 2026

Brookdale Senior Living Inc (BKD) Stock Down 3.0% but Still Over - GuruFocus

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQcDBPUzVYdlFMTEFaNXJaYVNLeThMd3d2RE9jNlBSRk1SdEpjMzZtU0VSQTF1TEVqTkVFcXR4ZmlNMlRFWVF2SEh4RWRPVXpNdW5tYVRCWlpaa3RhbkI4U0lNbzI3MmVOdVVYYWFoNldBNHFFa29mbFVZOEJIV25abjlpaVR1VnhuNnllOF…

Google News ue, 06 Oct 2026

3 Reasons to Sell BKD and 1 Stock to Buy Instead - FinancialContent

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNM3dKNEJTYzI2bmFlbW4wMnNid212d20zTGtQMk5EbE1jUkpleUt5OGNjV0Z6X01yUlJHSFQwalJHaGRJMVBsUzBvTURhMVg1eWZvaHVkS2NaZ2FJRG5Hc01PUEpFb2M0TmFaWmVSZ2xVWlB3QnBtV050R25leWZlTFI5bUdwWEpUcU5PZ2…

Google News hu, 25 Jun 2026

BKD Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE1DbVZjT1ZvUTZjWE5GWGFzb1VoX2hpd1R6Y016SDZZd0VJWnRaNUR6OHF0SHVtY185T1FTdU9ELWlZOVcwZTY0WnEtalpnZkZUWmhWUFNXOFJYSUxKOGdPcmU3MmVDN2t1UEFLM0JmUmVENjd5a3c?oc=5" target="_blank">BKD Fore…

Google News Mon, 05 Oct 2026

3 Reasons to Sell BKD and 1 Stock to Buy Instead - Barchart.com

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQWG9SMl9mbWtwUzM2Q2ZNdnNpMFBzeW9lTnhnYm9XdnRjYnIxLUJkbnFWUFZkR1k5TUNDMmliMVJlYWxFX1NEMGJtUFkzYzFHOTBsM1NfYnZsZDU2UXVGV0YtSHdodlRqa0k4UFBaVllGUnpDTFhzZDFjWldKSGRfUXFyOVRPYUVfc3hMQ1…

Google News Mon, 01 Jun 2026

Brookdale Senior Living: Revenue Down 6%, Debt Up, Yet Shockingly, The Stock Has Doubled - Seeking Alpha

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQSUxmeDhRZjhzWmJYWDZpRmFCckxGTHJsaU04c19TUjc4ekRUUXVOTlZGTzZLaWJra3VFNnNIbkdiWnhHWFpuSkpJN3dST3l0SzQxWW5PcmpJMTNNMm00eEk2OWhnM1J3RUlIdF83SzZ1YnlTNjRvZmZyRFRaUjExTUl0YjRhRFBRd2ZNb1…

BKD — Frequently Asked Questions

What is the current share price of Brookdale Senior Living Inc. (BKD)?

As of 2026-10-23 16:27 PDT, Brookdale Senior Living Inc. (BKD) trades at $10.08 on NYSE. Its 52-week range is $7.19 to $16.77.

What is the market capitalisation of BKD?

Brookdale Senior Living Inc. (BKD) has a market capitalisation of $2.41B on NYSE.

What is the P/E ratio of BKD?

BKD trades at a trailing price-to-earnings (P/E) ratio of -17.38. The industry average P/E is 25.45. Its price-to-book (P/B) ratio is -83.64.

Is BKD a good stock to buy?

This page provides a data-driven analysis of Brookdale Senior Living Inc. (BKD), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Brookdale Senior Living Inc. BKD R2KR3KPHARMA

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

3 Reasons to Sell BKD and 1 Stock to Buy Instead - Yahoo Finance

Brookdale Senior Living Inc (BKD) Stock Down 3.0% but Still Over - GuruFocus

3 Reasons to Sell BKD and 1 Stock to Buy Instead - FinancialContent

BKD Forecast — Price Target — Prediction for 2027 - TradingView

3 Reasons to Sell BKD and 1 Stock to Buy Instead - Barchart.com

Brookdale Senior Living: Revenue Down 6%, Debt Up, Yet Shockingly, The Stock Has Doubled - Seeking Alpha

BKD — Frequently Asked Questions

What is the current share price of Brookdale Senior Living Inc. (BKD)?

What is the market capitalisation of BKD?

What is the P/E ratio of BKD?

Is BKD a good stock to buy?

Explore More